Anastasia Krajec, RN

University of Colorado HospitalAurora, Colorado - 80045 (303-724-1871) |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS2
- SINCE2007

Placebo-Controlled Dose-Escalation Study of the Safety of IMO-2125 in Hepatitis C-Infected Patients
September 2007 - May 2010
Hepatitis
Hepatitis C
Placebo
Imo-2125



